Therapeutic beneficence and placebo controls

American Journal of Bioethics

Volumn 2, Issue 2, 2002, Pages 21-22

  Ackerman, Terrence F ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ANALYTICAL APPROACH; ARTICLE; BENEFICENCE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; ETHICS; HUMAN; HUMAN EXPERIMENT; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; RESEARCH ETHICS; RISK ASSESSMENT;

ANALYTICAL APPROACH; BIOMEDICAL AND BEHAVIORAL RESEARCH;

BENEFICENCE; CONTROL GROUPS; ETHICAL ANALYSIS; ETHICS, RESEARCH; HUMANS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 0036513788     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1162/152651602317533587     Document Type: Note

References (6)

1. Freedman, B. C., K. C. Glass, and C. Weijer. 1996a. Placebo orthodoxy in clinical research. I: Empirical and methodological myths. Journal of Law, Medicine, and Ethics 24:243-51.
2. Freedman, B. C. 1996b. Placebo orthodoxy in clinical research. II: Ethical, legal, and regulatory myths. Journal of Law, Medicine, and Ethics 24:252-59.
3. Miller, F. G., and H. Brody. 2002. What makes placebo-controlled trials unethical? American Journal of Bioethics 2(2):3-9.
4. Levine, R. J. 1986. Ethics and regulation of clinical research, 2nd ed. Baltimore: Urban and Schwarzenberg.
5. Veatch, R. M. 2002. Subject indifference and the justification of placebo- controlled trials. American Journal of Bioethics 2(2):12-13.
6. World Medical Association. 2000. Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 284:3043-45.